Keros Therapeutics Inc (KROS)
11.44 +0.02 (+0.18%) 03/20/25 [NASDAQ]
11.07 x 700 11.99 x 300
Realtime by (Cboe BZX)
11.07 x 700 11.99 x 300
Realtime - - (-) -
for Thu, Mar 20th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 559,931 | 530,684 | 405,863 | 442,443 | 331,147 |
| Receivables | 2,742 | 388 | 4 | 226 | 143 |
| TOTAL | $588,893 | $552,046 | $432,714 | $463,126 | $347,293 |
| Non-Current Assets | |||||
| PPE Net | 4,237 | 4,366 | 4,292 | 4,434 | 4,134 |
| Other Non-Current Assets | 22,756 | 22,859 | 18,016 | 18,259 | 18,598 |
| TOTAL | $26,993 | $27,225 | $22,308 | $22,693 | $22,732 |
| Total Assets | $615,886 | $579,271 | $455,022 | $485,819 | $370,025 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,602 | 4,981 | 6,535 | 4,986 | 5,450 |
| Accrued Expenses | 20,870 | 22,169 | 13,614 | 12,682 | 17,918 |
| TOTAL | $27,450 | $29,007 | $21,245 | $18,718 | $24,373 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 16,883 | 17,429 | 12,861 | 13,154 | 13,439 |
| TOTAL | $16,883 | $17,429 | $12,861 | $13,154 | $13,439 |
| Total Liabilities | $44,333 | $46,436 | $34,106 | $31,872 | $37,812 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,562 | 40,507 | 37,522 | 36,084 | 35,983 |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -568,779 | -522,753 | -469,797 | -424,540 | -381,426 |
| TOTAL | $571,553 | $532,835 | $420,916 | $453,947 | $332,213 |
| Total Liabilities And Equity | $615,886 | $579,271 | $455,022 | $485,819 | $370,025 |